| 发明名称 |
METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER |
| 摘要 |
The present invention provides methods of treating, stabilizing or lessening the severity or progression of a disease or disorder associated with BTK. |
| 申请公布号 |
US2016287588(A1) |
申请公布日期 |
2016.10.06 |
| 申请号 |
US201615178299 |
申请日期 |
2016.06.09 |
| 申请人 |
Celgene Avilomics Research, Inc. |
发明人 |
Witowski Steven Richard;Westlin, III William Frederick;Lounsbury Heather;Stiede Kathryn;Silver Bruce A.;Mei Jay M. |
| 分类号 |
A61K31/506;A61K9/48;A61K9/00 |
主分类号 |
A61K31/506 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating, stabilizing or lessening the severity or progression of a disease or disorder selected from the group consisting of B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia and Waldenstrom's macroglobulinemia, the method comprising administering to a patient in need thereof a pharmaceutically acceptable composition comprising N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide (1): |
| 地址 |
Cambridge MA US |
